Hyperbaric oxygen induces placental growth factor expression in bone marrow-derived mesenchymal stem cells.

The bone marrow is home to mesenchymal stem cells (MSCs) that are able to differentiate into many different cell types. The effect of hyperbaric oxygen (HBO) on MSCs is poorly understood. Placental growth factor (PlGF) is an attractive therapeutic agent for stimulating revascularization of ischemic tissue. HBO has been shown to improve diabetic wound healing by increase circulating stem cells. We hypothesized that HBO induces PlGF expression in bone marrow-derived MSCs. The MSCs were obtained from adult human bone marrow and expanded in vitro. The purity and characteristics of MSCs were identified by flow cytometry and immunophenotyping. HBO at 2.5 ATA (atmosphere absolute) significantly increased PlGF protein and mRNA expression. The induction of PlGF protein by HBO was significantly blocked by the addition of N-acetylcysteine, while wortmannin, PD98059, SP600125 and SB203580 had no effect on PlGF protein expression. However, the specific inhibitor of nitric oxide synthase, L-NAME did not alter the PlGF protein expression induced by HBO. HBO significantly increased the reactive oxygen species production and pretreatment with N-acetylcysteine significantly blocked the induction of reactive oxygen species by HBO. HBO significantly increased the migration and tube formation of MSCs and pretreatment with N-acetylcysteine and PlGF siRNA significantly blocked the induction of migration and tube formation by HBO. In conclusion, HBO induced the expression of PlGF in human bone marrow-derived MSCs at least through the oxidative stress-related pathways, which may play an important role in HBO-induced vasculogenesis.

[1]  D. Buerk,et al.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. , 2007, The Journal of clinical investigation.

[2]  M. McGrath,et al.  Peptide growth factors and wound healing. , 1990, Clinics in plastic surgery.

[3]  Chun-chung Lee,et al.  Hyperbaric oxygen selectively induces angiopoietin-2 in human umbilical vein endothelial cells. , 2002, Biochemical and biophysical research communications.

[4]  J. Daly.  Placenta Growth Factor in Diabetic Wound Healing: Altered Expression and Therapeutic Potential , 2009 .

[5]  A. Luttun,et al.  Placental growth factor and its receptor, vascular endothelial growth factor receptor‐1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders , 2003, Journal of thrombosis and haemostasis : JTH.

[6]  ToyoakiMurohara,et al.  Therapeutic Angiogenesis Using Novel Vascular Endothelial Growth Factor-E/Human Placental Growth Factor Chimera Genes , 2007 .

[7]  Till Acker,et al.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.

[8]  M. Putt,et al.  The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. , 2006, Journal of vascular surgery.

[9]  S. Thom.  Hyperbaric-oxygen therapy for acute carbon monoxide poisoning. , 2002, The New England journal of medicine.

[10]  N. Haugaard.  Cellular mechanisms of oxygen toxicity. , 1968, Physiological reviews.

[11]  R. Marx,et al.  Relationship of oxygen dose to angiogenesis induction in irradiated tissue. , 1990, American journal of surgery.

[12]  G. Zambruno,et al.  The placenta growth factor in skin angiogenesis. , 2006, Journal of dermatological science.

[13]  J. Schultz,et al.  Studies on the chlorinating activity of myeloperoxidase. , 1976, The Journal of biological chemistry.

[14]  Chun-chung Lee,et al.  GL331 inhibits HIF-1α expression in a lung cancer model , 2003 .

[15]  K. Fukuda,et al.  Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. , 2001, Artificial organs.

[16]  Horng-mo Lee,et al.  Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. , 2006, Journal of biomedical science.

[17]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[18]  E. Masson,et al.  The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[19]  A. Harabin,et al.  Response of antioxidant enzymes to intermittent and continuous hyperbaric oxygen. , 1990, Journal of applied physiology.

[20]  J. Heinecke.  Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis , 1997, Current opinion in lipidology.

[21]  G. Breier,et al.  The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.

[22]  T. K. Hunt,et al.  Oxygen and wound healing. , 1990, Clinics in plastic surgery.

[23]  P. Cronier,et al.  Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled clinical trial. , 1996, The Journal of trauma.

[24]  I. Weissman,et al.  Translating stem and progenitor cell biology to the clinic: barriers and opportunities. , 2000, Science.

[25]  K. Shyu,et al.  Regulation of hypoxia-inducible factor-1alpha by cyclical mechanical stretch in rat vascular smooth muscle cells. , 2003, Clinical science.

[26]  D. Buerk,et al.  Endothelial Progenitor Cell Release into Circulation Is Triggered by Hyperoxia‐Induced Increases in Bone Marrow Nitric Oxide , 2006, Stem cells.

[27]  F. Gürdöl,et al.  Early and late effects of hyperbaric oxygen treatment on oxidative stress parameters in diabetic patients. , 2008, Physiological research.

[28]  A. Jaiswal,et al.  Nrf2 signaling in coordinated activation of antioxidant gene expression. , 2004, Free radical biology & medicine.

[29]  A. Gill,et al.  Hyperbaric oxygen: its uses, mechanisms of action and outcomes. , 2004, QJM : monthly journal of the Association of Physicians.

[30]  Yu‐hui Yang,et al.  Amphetamine activates connexin43 gene expression in cultured neonatal rat cardiomyocytes through JNK and AP-1 pathway. , 2004, Cardiovascular research.

[31]  N. Andrews.  Molecules in focus The NF-E2 transcription factor , 1998 .

[32]  Lynne H. Thom,et al.  Stem cell mobilization by hyperbaric oxygen , 2006, American journal of physiology. Heart and circulatory physiology.

[33]  H. Dvorak,et al.  VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. , 2003, Trends in cardiovascular medicine.

[34]  K. Shyu,et al.  Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. , 2006, Journal of biomedical science.

[35]  Peter Carmeliet,et al.  VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  H. Mclennan,et al.  The Contribution of Mitochondrial Respiratory Complexes to the Production of Reactive Oxygen Species , 2000, Journal of bioenergetics and biomembranes.

[37]  T. Ushida,et al.  Effects of hyperbaric oxygen on procollagen messenger RNA levels and collagen synthesis in the healing of rat tendon laceration. , 1999, Tissue engineering.

[38]  H. Dvorak,et al.  Roles in Angiogenesis and Arteriogenesis , 2003 .

[39]  S. Rafii,et al.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment , 2002, Nature Medicine.

[40]  D. Buerk,et al.  Stimulation of perivascular nitric oxide synthesis by oxygen. , 2003, American journal of physiology. Heart and circulatory physiology.